Earn up to 1.0 Professional CLE for NJ/NY
Important considerations when presenting before a district court will be discussed, such as credibility, scientific truth versus burden of proof.
Keynote Speaker: Honorable Sue L. Robinson Former U.S. District Judge Sue L. Robinson joined Farnan LLP after her retirement from the bench in July 2017. Her practice focuses on consulting in complex commercial litigation, mock trials and arguments, alternative dispute resolution, and arbitration. [Read more]
Moderator: Stephanie Donahue, Principal Counsel, Patent Litigation, Sanofi
Stephanie is responsible for managing patent infringement litigation brought by and against Sanofi. In that role, among other things, she develops and executes strategic patent infringement litigation action plans, negotiates patent infringement settlements, and communicates case developments and litigation risks to senior management.
GoToWebinar Note: Once you register, you will receive a GoToWebinar confirmation e-mail with a unique link to join the session. Click "Add to calendar" to ensure you don't miss the webinar.
Thank You To Our Sponsor
Chemical Practice Co-Chairs J. Eric Thies, Merck & Co., Inc. and Suja Vathyam, Botos Churchill IP Law LLP
34th Annual Pharmaceutical/Chemical Patent Practice Update Webinar SeriesEarn up to 1.0 Professional CLE for NJ/NY
The presentation will highlight the latest supplementary protection certificate (SPC) news in Europe from the perspectives of prosecution, enforcement and policy.
Speakers Kristina Cornish, Nick Bassil, and Benjamin Heller of Kilburn & Strodei
Moderators J. Eric Thies, Merck & Co., Inc. and Suja Vathyam, Botos Churchill IP Law LLP
With continued significant investment by venture, PE, and pharma communities in biotech clusters around the world, ensuring that your portfolio can provide maximum value on a global scale for ultimate partnering or acquisition is a crucial element of any startup’s strategic plan. Teresa will discuss important considerations such as: Balancing early filing/first to file realities with meeting enablement and support requirements in the US and around the world; best practices for working with CROs, consultants, and universities; and details such as inventorship, ownership, and chain of title.
Speaker Teresa A. Lavoie, Fish & Richardson
Dr. Teresa Lavoie has developed, managed, and overseen the sale of patent portfolios worth more than $33 billion in deal value. Her international practice focuses on strategic patent counseling, prosecution, and portfolio development advice, including patent opinions, due diligence, freedom-to-operate analyses, and life cycle management strategies. Dr. Lavoie’s clients range from start-up and emerging companies developing life-saving therapeutics and diagnostics to academic and research institutions inventing disruptive platform technologies for the biotechnology and biopharma industries. She has extensive experience in the areas of small-molecule and biologic pharmaceuticals (including antibody technologies and immunotherapies, such as CAR-T therapies), drug formulation and drug delivery technologies, diagnostics, clean and alternative (animal- and environmentally-friendly) food technologies, protein biochemistry and engineering, cell systems engineering, nanotechnologies, plant biotechnology and genomics, and green/environmental chemistries. Dr. Lavoie also has significant transactional experience in various aspects of IP licensing, including sponsored research, feasibility, and development and commercialization agreements. [Read more]
Genus claims continue to be a focus of scrutiny by the courts. In Amgen v. Sanofi (No. 20-1074), the Federal Circuit is poised to decide yet another gateway issue concerning the patentability of biotech inventions. The court will consider whether two patents that claim a genus of antibodies satisfy the enablement requirement under 35 U.S.C. §112. Given that antibody technologies require a huge investment and are thought to be one of the most promising approaches to treat diseases today, the Federal Circuit’s forthcoming decision in Amgen v. Sanofi is likely to have a profound impact on the biotech industry.
SpeakersClara N. Jimenez, Johnson &Johnson
Clara N. Jiménez is Senior Counsel in Johnson & Johnson’s IP Litigation Group which supports the J&J businesses in all aspects of intellectual property litigation across the globe.
Preston K. Ratliff II, Paul Hastings
Preston K. Ratliff II is the Chair of the Firm’s Litigation practice in New York. Mr. Ratliff focuses his practice on complex, high-stakes patent litigation with an emphasis on the biotechnology, pharmaceutical, chemical, agricultural, and renewable fuel sectors. [Read more]
34th Annual Pharmaceutical/Chemical Patent Practice Update Webinar SeriesEarn up to 1.0 Ethics CLE for NJ/NY
An overview of several core aspects of legal ethics and practice before the USPTO. The presentation begins by briefly touching on various OED programs and initiatives, and then moves to a description of select regulations governing the USPTO’s disciplinary process and statistics regarding recent disciplinary orders. The presentation concludes with a thorough discussion of select case law relevant to practice before the USPTO in patent and trademark matters with an emphasis on USPTO disciplinary decisions and the USPTO Rules of Professional Conduct.
Speaker William Covey, USPTO OED DirectorAs Deputy General Counsel and Director for the Office of Enrollment and Discipline (OED), Will Covey is responsible for ensuring that the nation’s patent attorneys and agents are of good moral character and sufficiently knowledgeable to practice before the USPTO. Mr. Covey’s team of attorneys and other professionals develop and administer a registration examination designed to measure applicants' knowledge of patent law and practice. Successful applicants are registered to practice by OED. In addition, OED investigates complaints of unethical conduct made against individuals practicing patent or trademark law before the USPTO.
NJIPLA is pleased to announce our
Hon. Jimmie V. Reyna
Circuit Judge, United States Court of Appeals for the Federal Circuit
We hope you can join us as we honor Judge Jimmie Reyna with the
Jefferson Medal at our annual gala to be held at a new location:
The American Beauty Ballroom in the newly constructed
Embassy Suites by Hilton in Berkeley Heights, NJ.
Early-Bird Registration ends April 30.
New this year, dinner wine service will be included in the reception and dinner rate.
*Table for 10 Reservation
A table has a total of 10 seats, which includes 1 seat reserved for an Honored Guest. NJIPLA does not guarantee an Honored Guest at each table. The Honored Guest may also bring a guest, and if so, NJIPLA will add a seat to your table at no additional cost. Your firm's 9 Guest Names for the table must be provided by April 30.
Hotel Sleeping Room Reservation
A special NJIPLA room rate of $149.00 for Friday night (excluding tax) has been established. This accommodation is offered on a first-come, first-served basis until April 30.
You may book online Embassy Suites or call 1-844-714-1511.
Group Code: NJI
Group Name: Jefferson Medal Dinner Room Block
NJIPLA is pleased to offer sponsorship opportunities for our 2021 Jefferson Medal Dinner. Benefits are recognition in our pre-event emails, logo and link on the NJIPLA website, includes a Congratulatory Notice, acknowledgement of sponsorship during the event welcome remarks, and much more.
Congratulatory Notice $400.00
Congratulatory artwork must be submitted to email@example.com no later than April 30, 2021. All submissions are subject to the review and approval of NJIPLA in its sole discretion.
Specification - Size: 6' W x 9' H, Color: Black/White only, Artwork Format: PDF. Limit 1 page per firm/company.
Content is limited to appropriate expression of honor to the Jefferson Medal award recipient:
Free self-parking. Park in the rear to easily access the main entrance to the Reception and American Beauty Ballroom (Level 2).
A free shuttle bus will be available to and from Embassy Suites and Berkeley Heights Train Station or Netherwood Train Station during the day of the dinner. When you arrive at the train station, please call the hotel's front desk (908) 897-1970.
Refund / Cancellation Policy
No refunds or cancellations after April 30, 2021. Dinner reservations are transferable.
New Jersey Intellectual Property Law Association (NJIPLA)c/o RRR Associations, LLC2125 Center Avenue, Suite 406, Fort Lee, NJ, 07024